Methods & Compositions for the Activation of Gamma-delta T-cells
Country:
US
Docket No:
436313-003117
Publication Number:
10,420,789
Patent Expiry:
01/13/2037
Claims Scope:
Patent issued September 24, 2019.
Sequence Agnostic – Composition only
Composition of a bisphosphonate drug in combination with a lentiviral particle encoding either shRNA or microRNA capable of inhibiting FDPS.
